Management Team

Marcia Lewis, Ph.D., Vice President, Biomarker Development – Marcia Lewis, Ph.D. was most recently the Senior Director of Oncology Programs at Celera where she focused on the identification and validation of diagnostic biomarkers for oncology discovered via Celera's proprietary proteomics platform. While at Celera, she represented the company on the Biomarker Working Group for the Pharmaceutical Research and Manufacturers of America (PhRMA). Prior to Celera, Dr. Lewis spent 13 years at Bayer Diagnostics in various positions including that of Director of Genomics and Bioinformatics, Program Manager of the Colorectal Cancer Program, and Project Manager of Nucleic Acid Diagnostics and Corporate Research. She also served on the Board of Directors of the SNP Consortium where she represented the Bayer AG organization. Dr. Lewis has a B.S. from Cornell University in Biological Sciences. She has an M.S. in Microbiology from the University of Georgia and a Ph.D. from the University of Alberta in Basic Medical Sciences (Neurovirology); she also completed a postdoctoral fellowship at Yale University School of Medicine. Dr. Lewis currently serves on the editorial board of Biomarkers in Medicine.